Low concentrations of estradiol reduce β-amyloid (25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells

Brain Research

Volumn 778, Issue 1, 1997, Pages 158-165

  Gridley, Kelly E ^a   Green, Pattie S ^a   Simpkins, James W ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Amyloid; Estradiol; Glucose utilization; Lactate production; Lipid peroxidation; SK N SH neuroblastoma cell

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ESTRADIOL;

ARTICLE; CELL METABOLISM; CELL VIABILITY; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LACTATE BLOOD LEVEL; LIPID PEROXIDATION; NEUROBLASTOMA; NEUROBLASTOMA CELL; NEUROPROTECTION; PRIORITY JOURNAL;

AMYLOID BETA-PROTEIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; GLUCOSE; HUMANS; LACTIC ACID; LIPID PEROXIDATION; NEUROBLASTOMA; NEURONS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; TUMOR CELLS, CULTURED;

EID: 0031555397     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01056-1     Document Type: Article

References (44)

1. Aronson M.K., Ooi W.L., Morgenstern H., Hafner A., Masur D., Crystal H., Frishman W.H., Fisher D., Katzman R. Women, myocardial infarction, and dementia in the very old. Behav. Neural Biol. 40:1990;1102-1106.
2. Behl C., Davis J.B., Klier F.G., Schubert D. Amyloid β peptide induces necrosis rather than apoptosis. Brain Res. 645:1994;253-264.
3. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell. 77:1994;817-827.
4. Behl C., Widmann M., Trapp T., Holsboer F. 17β-Estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216:1995;473-482.
5. Ben-Yoseph O., Boxer P.A., Ross B.D. Assessment of the role of glutathione and pentose phosphate pathways in the protection of primary cerebrocortical cultures from oxidative stress. J. Neurochem. 66:1996;2329-2337.
6. Bishop J., Simpkins J.W. Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro. Mol. Cell. Neurosci. 5:1994;303-308.
7. Black L., Berenbaum M.C. Factors affecting the dye exclusion test for cell viability. Exp. Cell Res. 35:1964;9-13.
8. Craft S., Zallen G., Baker L.D. Glucose and memory in mild senile dementia of the Alzheimer type. J. Clin. Exp. Neuropsychol. 14:1992;253-267.
9. Davis R.E., Miller S., Herrnstadt C., Ghosh S.S., Fahy E., Shinobu L.A., Galasko D., Thal L.J., Beal M.F., Howell N., Parker J., Davis W. Mutations in mitochondrial cytochrome-c oxidase genes segregate with late-onset Alzheimer diseasee. Proc. Natl. Acad. Sci. USA. 94:1997;4526-4531.
10. Estevez A.G., Radi R., Barbeito L., Shin J.T., Thompson J.A., Beckman J.S. Peroxy-induced cytotoxicity in PC12 cells: evidence for an apoptotic mechanism differentially modulated by neurotrophic factors. J. Neurochem. 65:1995;1543-1550.
11. Galli G., Fratelli M. Activation of apoptosis by serum deprivation in a teratocarcinoma cell line: inhibition by L-acetylcarnitine. Exp. Cell Res. 204:1993;54-60.
12. Glenner G.G., Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120:1984;885-890.
13. Gold P.E. Glucose modulation of memory storage processing. Behav. Neural Biol. 45:1986;342-349.
14. Goodman Y., Bruce A.J., Cheng B., Mattson M.P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem. 66:1996;1836-1844.
15. Green P.S., Bishop J., Simpkins J.W. 17α-Estradiol exerts neuroprotective effects on SK-N-SH cells. J. Neurosci. 17:1997;511-515.
16. Green P.S., Gridley K.E., Simpkins J.W. Estradiol protects against β-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci. Lett. 218:1996;165-168.
17. Haxby J.V., Grady C.L., Koss E., Horwitz B., Heston L., Schapiro M., Friedland R.P., Papoport S.I. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch. Neurol. 47:1990;753-760.
18. Katzman R. Alzheimer's Disease. N. Engl. J. Med. 314:1986;964-973.
19. Kennedy A.M., Frackowiak R.S.J., Newman S.K., Bloomfield P.M., Seaward J., Roques P., Lewington G., Cunningham V.J., Rossor M.N. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neurosci. Lett. 186:1995;17-20.
20. Loo D.T., Copani A., Pike C.J., Whittemore E.R., Walencewicz A.J., Cotman C.W. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA. 90:1993;7951-7955.
21. Mattson M.P., Tomaselli K.J., Rydel R.E. Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res. 621:1993;35-49.
22. Max W. The economic impact of Alzheimer's disease. Neurology. 43(S4):1993;S6-S10.
23. Maziere C., Auclair M., Ronveaux M.-F., Salmon S., Santus R., Maziere J.-C. Estrogens inhibit copper and cell-mediated modification of low density lipoprotein. Artherosclerosis. 89:1991;175-182.
24. Meister A., Anderson M.E. Glutathione. Annu. Rev. Biochem. 52:1983;711-760.
25. Messier C., Destrade C. Improvement of memory for an operant response by post-training glucose in mice. Behav. Brain Res. 31:1988;185-191.
26. Mooradian A.D. Antioxidant properties of steroids. J. Steroid Biochem. Mol. Biol. 45:1993;509-511.
27. Mukai K., Daifuku K., Yokoyama S., Nakano M. Stopped-flow investigation of antioxidant actvity of estrogens in solution. Biochim. Biophys. Acta. 1035:1990;348-352.
28. Murphy T., Miyamoto M., Sastre A., Schnaar R., Coyle J. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron. 2:1989;1547-1558.
29. Nakano M., Sugioka K., Naito I., Takekoshi S., Niki E. Novel and potent biological antioxidants on membrane phospholipid peroxidation: 2-hydroxy estrone and 2-hydroxy estradiol. Biochem. Biophys. Res. Commun. 142:1987;919-924.
30. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:1979;351-358.
31. Paganini-Hill A., Henderson V.W. Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol. 140:1994;256-261.
32. Pike C.J., Walencewicz A.J., Glabe C.G., Cotman C.W. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563:1991;311-314.
33. Reiman E.M., Caselli R.J., Yun L.S., Chen K., Bandy D., Minoshima S., Thibodeau S.N., Osborne D. Preclinical evidence of Alzheimer's disease in persons homozygous for the e4 allele for apolipoprotein E. N. Eng. J. Med. 334:1996;752-758.
34. Rifici V.A., Khachadurian A.K. The inhibition of low-density lipoprotein oxidation by 17β- estradiol. Metabolism. 41:1992;1110-1114.
35. Selkoe D.J. Alzheimer's disease: genotypes, phenotype, and treatments. Science. 275:1997;630-631.
36. Simonian N.A., Hyman B.T. Functional alterations in Alzheimer's disease: diminution of cytochrome oxidase in the hippocampal formation. J. Neuropathol. Exp. Neurol. 52:1993;580-595.
37. Simpson I.A., Chundu K.R., Davies-Hill T., Honer W.G., Davies P. Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Ann. Neurol. 35:1994;546-551.
38. Singer C.A., Strickland T.M., Rogers K.L., Dorsa D.M. Estrogen protects primary cortical neurons from glutamate neurotoxicity. Neurosci. Lett. 212:1996;13-16.
39. Small G.W., Mazziotta J.C., Collins M.T., Baxter L.R., Phelps M.E., Mandelkern M.A., Kaplan A., La Rue A., Adamson C.F., Chang L., Guze B.H., Corder E.H., Saunders A.M., Haines J.L., Pericak-Vance M.A., Roses A.D. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer's disease. J. Am. Med. Assoc. 273:1995;942-947.
40. Subbarao K.V., Richardson J.S. Iron-dependent peroxidation of rat brain: A regional study. J. Neurosci. Res. 26:1990;224-232.
41. Sugioka K., Shimosegawa Y., Nakano M. Estrogens as natural antioxidants of membrane phospholipid peroxidation. FEBS Lett. 210:1987;37-39.
42. Tang M.-X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 348:1996;429-432.
43. Yankner B.A., Dawes L.R., Fisher S., Villa-Koaroff L., Oster-Granite M.L., Neve R.L. Neurotoxicity of fragment of the amyloid precursor associated with Alzheimer's disease. Science. 245:1989;417-520.
44. Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science. 250:1990;279-282.